Association Between Potency Critical Quality Attributes and Clinical Efficacy Across Lentiviral Vector Cell and Gene Therapy Products

被引：0
|
作者：
Shestopalov, Ilya A. [1 ]
Jiang, Hancheng [1 ]
Gayron, Marisa [1 ]
d'Anjou, Marc [1 ]
Kral, Kelly [1 ]
Pierciey, Francis J. [1 ]
Colvin, Richard [1 ]
机构：
[1] Bluebird Bio, Somerville, MA USA
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
238
引用
收藏
页码：127 / 128
页数：2
相关论文
共 28 条
  • [21] Integration Site Analysis in a Clinical Trial of Lentiviral Vector Based Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy. An 18 Months Follow-Up
    Montini, Eugenio
    Biffi, Alessandra
    Calabria, Andrea
    Biasco, Luca
    Cesani, Martina
    Benedicenti, Fabrizio
    Plati, Tiziana
    Leo, Simone
    Neduva, Victor
    Zanetti, Gianluigi
    Aiuti, Alessandro
    Dow, David
    von Kalle, Christof
    Schmidt, Manfred
    Sessa, Maria
    Naldini, Luigi
    MOLECULAR THERAPY, 2013, 21 : S119 - S119
  • [22] Hematopoietic Stem Cell Gene Therapy with Lentiviral Vector in 4 Patients with Cerebral X-Linked Adrenoleukodystrophy: Long-Term Outcome and Comparison of Efficacy with Allogeneic Hematopoietic Stem Cell Transplantation
    Orchard, Paul
    Cartier, Nathalie
    Hacein-Bey-Abina, Salima
    Kurtzberg, Joanne
    Escolar, Maria
    Tolar, Jakub
    Baruchel, Andre
    Dalle, Jean-Hughes
    Michel, Gerard
    Blanche, Stephane
    Bartholomae, Cynthia
    Schmidt, Manfred
    Bougneres, Pierre
    van Kalle, Christof
    Cavazzana-Calvo, Marina
    Fischer, Alain
    Aubourg, Patrick
    MOLECULAR THERAPY, 2013, 21 : S25 - S26
  • [23] Hematopoietic stem cell gene therapy with lentiviral vector in 4 patients with cerebral X-linked adrenoleukodystrophy: long-term outcome and comparison of efficacy with allogeneic hematopoietic stem cell transplantation
    Cartier, Nathalie
    HUMAN GENE THERAPY, 2015, 26 (09) : A2 - A2
  • [24] Hematopoietic stem cell gene therapy with lentiviral vector in 4 patients with cerebral X-linked adrenoleukodystrophy: long-term outcome and comparison of efficacy with allogeneic hematopoietic stem cell transplantation
    Orchard, P.
    Cartier, N.
    Hacein-Bey-Abina, S.
    Kurtzberg, J.
    Escolar, M.
    Tolar, J.
    Baruchel, A.
    Dalle, J-H.
    Michel, G.
    Blanche, S.
    Bartholomae, C.
    Schmidt, M.
    Bougneres, P.
    Von Kalle, C.
    Cavazzana-Calvo, M.
    Fischer, A.
    Aubourg, P.
    HUMAN GENE THERAPY, 2013, 24 (12) : A21 - A21
  • [25] Continuing Clinical Efficacy and ALDP Gene Expression 5-10 Years after Lentiviral LV-Based CD34+Cell Gene Therapy in Patients with X-linked Adrenoleukodystrophy (X-ALD)
    Aubourg, Patrick
    Adamsbaum, Catherine
    Dufayet, Gaelle
    Laurendeau, Ingrid
    Fouquet, Francoise
    Vidaud, Michel
    Blanche, Stephane
    Cavazzana, Marina
    Cartier, Nathalie
    Fischer, Alain
    Abina, Salima Hacein-Bey
    Bougneres, Pierre
    MOLECULAR THERAPY, 2020, 28 (04) : 277 - 278
  • [26] Clinical Association Between Immune-related Adverse Events and Treatment Efficacy in Patients With Non-small-cell Lung Cancer Treated With Nivolumab-Ipilimumab-based Therapy
    Ebi, Noriyuki
    Inoue, Hiroyuki
    Igata, Fumiyasu
    Okuma, Rei
    Kinoshita, Eriko
    Kawabata, Toshiaki
    Tan, Ibun
    Osaki, Yusuke
    Ikeda, Takato
    Nakao, Akira
    Shundo, Yuki
    Hamada, Naoki
    Fujita, Masaki
    ANTICANCER RESEARCH, 2024, 44 (07) : 3087 - 3095
  • [27] Non-clinical, quality and environmental impact assessments of cell and gene therapy products: Report on the 5th Asia Partnership Conference of Regenerative Medicine-April 7, 2022
    Tanaka, Toshimitsu
    Karasawa, Hiroshi
    Yasumoto, Masahiko
    Choi, Byung Hyune
    Chang, Ryan
    Komuro, Masato
    Miyano, Masaaki.
    Moriya, Yuu
    Muthusamy, Sasikumar
    Okubo, Shingo
    Takakura, Koji
    Tsurumaki, Yoshie
    Watanabe, Takeshi
    Wen, Karen
    Yoneda, Tomohiro
    Yuan, Ta-Tung
    Nomura, Masayuki
    CYTOTHERAPY, 2023, 25 (07) : 683 - 698
  • [28] Association of gene expression signature and clinical efficacy of MAGE-A3 antigen-specific cancer immunotherapeutic (ASCI) as adjuvant therapy in resected stage IB/II non-small cell lung cancer (NSCLC)
    Vansteenkiste, J. F.
    Zielinski, M.
    Dahabreh, I. J.
    Linder, A.
    Lehmann, F.
    Gruselle, O.
    Therasse, P.
    Louahed, J.
    Brichard, V. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
123